Difficulty: Medium
Average Score: 86%
Practice
An adult patient has been taking a drug (Drug A) that is highly metabolized by the cytochrome p-450 system. He has been on this medication for 6 months. At this time, he is started on a second medication (Drug B) that is an inducer of the cytochrome p-450 system. You should monitor this patient for:
Correct answer
C
Rationale
Drug B, as an inducer of the cytochrome p-450 system, increases the metabolism of Drug A, leading to lower plasma concentrations and reduced therapeutic effects of Drug A. This interaction is a common concern in polypharmacy, where one drug affects the metabolism of another. Monitoring for decreased efficacy of Drug A is essential to ensure the patient receives adequate treatment. Increased adverse effects of Drug B or decreased effects of Drug B are less likely in this scenario.